The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Alpha Cognition Inc. (ACOG) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? Let's take a closer look at the stock's year-to-date performance to find out.
Alpha Cognition Inc. is a member of the Medical sector. This group includes 950 individual stocks and currently holds a Zacks Sector Rank of #4. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. Alpha Cognition Inc. is currently sporting a Zacks Rank of #2 (Buy).
Over the past three months, the Zacks Consensus Estimate for ACOG's full-year earnings has moved 30% higher. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.
Our latest available data shows that ACOG has returned about 8.2% since the start of the calendar year. At the same time, Medical stocks have gained an average of 6.5%. This means that Alpha Cognition Inc. is performing better than its sector in terms of year-to-date returns.
One other Medical stock that has outperformed the sector so far this year is Actinium Pharmaceuticals (ATNM). The stock is up 15.1% year-to-date.
The consensus estimate for Actinium Pharmaceuticals' current year EPS has increased 11.7% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, Alpha Cognition Inc. belongs to the Medical - Biomedical and Genetics industry, a group that includes 467 individual stocks and currently sits at #91 in the Zacks Industry Rank. On average, stocks in this group have gained 19.9% this year, meaning that ACOG is slightly underperforming its industry in terms of year-to-date returns.
Actinium Pharmaceuticals, however, belongs to the Medical - Drugs industry. Currently, this 147-stock industry is ranked #79. The industry has moved +7.9% so far this year.
Investors interested in the Medical sector may want to keep a close eye on Alpha Cognition Inc. and Actinium Pharmaceuticals as they attempt to continue their solid performance.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Alpha Cognition Inc. (ACOG): Free Stock Analysis Report Actinium Pharmaceuticals, Inc. (ATNM): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
